PILA PHARMA AB

Share · SE0015988274 · A3CT5N (XSTO)

Overview

No Price

Closing Price XSTO 06.03.2026: 1,18 SEK

06.03.2026 15:16

Current Prices from PILA PHARMA AB

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ STOCKHOLM AB	PILA.ST	SEK	06.03.2026 15:16	1,18 SEK	-0,06 SEK -5,14 %
Frankfurt	5KC.F	EUR	27.02.2026 14:25	0,11 EUR	-

Share Float & Liquidity

Free Float 31,01 %

Shares Float 14,17 M

Shares Outstanding 45,68 M

Company Profile for PILA PHARMA AB Share

PILA PHARMA AB (publ) operates as a clinical stage pharmaceutical company in Sweden. It is developing XEN-D0501, a TRPV1 antagonist that has completed two phase 2a clinical trials for type 2 diabetes. PILA PHARMA AB (publ) was incorporated in 2014 and is based in Malmö, Sweden.

AI Analysis of PILA PHARMA AB

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of PILA PHARMA AB

No AI threads available for this company yet.

Company Data

Name PILA PHARMA AB

Company Pila Pharma AB (publ)

Website https://pilapharma.com

Primary Exchange

Frankfurt

WKN A3CT5N

ISIN SE0015988274

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Gustav Hanghoj Gram

Market Capitalization 54 Mio

Country Sweden

Currency EUR

Employees 0,0 T

Address VAestergatan 1, 211 21 Malmö

IPO Date 2021-07-15

Ticker Symbols

Name	Symbol
NASDAQ STOCKHOLM AB	PILA.ST
Frankfurt	5KC.F

More Shares

Investors who hold PILA PHARMA AB also have the following shares in their portfolio:

Bionano Genomics, Inc. - Common Stock Share

RESIDENTIAL MORTGAGE SECURITIES 10 PLC CLASS 'A2'MTG BCKD FRN 10/08/29 (144A) Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog